Sociological Evaluation of Pharmaceutical Activity: Determining the Subject Field


  • Stanislav Knyazkov M. P. Dragomanov National Pedagogical University



sociology of medicine, medicalization, institute of pharmacy


Over the past decades, the expansion of the subject field of sociology has continued. One of these pioneering and, at the same time, practically oriented areas is the sociological evolution of the functioning of the health care system. Under the conditions of reforming this system, the perception of relevant managerial innovations by the population becomes of special significance. The corresponding transformation of political and managerial approaches to regulation of the healthcare and pharmaceutical sector is taking place today in Ukrainian society. In particular, it is about such innovations as: Government program «Available medicines», which provides for full or partial reimbursement of the cost of drugs from number of diseases; change of mechanisms of state procurement of medicines (expansion of control of international non-governmental organizations for state purchases of medicines); regulation of prices on the basis of reference pricing; creation of the electronic base of E-health – an integrated register of medical institutions, doctors and patients etc. The subject field of sociological evolution of the functioning of the institution of pharmacy covers a range of issues such as: studying the awareness of citizens about the organization of the population supply with medicinal products; identification of the factors of choice of drugs and mechanisms of provision of pharmaceutical services by the consumers; assessing the effectiveness of the pharmaceutical sector reform efforts by individuals and groups involved in these processes; clarification of the degree of satisfaction of consumers of medicinal products with quality, price of medicinal products, level of pharmaceutical services, etc.


Androsiuk, H. M., Shtyk, O. I. (2014). Social Health of Ukrainian Society. Sociological studios, No 4, Vol. 1, Pp. 69–76.

Bondarieva, I. V., Pestun, I. V., Sakipova, Z. B. (2014). «Comparative analysis methods of evaluation adapting Ukrainian pharmaceutical enterprises to external changes». Pharmaceutical magazine, Vol. 4, Pp. 4–8.

Kotvicka, A. (2008). «Methodology of social justice of pharmaceutical supply to population». Pharmaceutical magazine, No 2, Pp. 8–12.

Ministry of health. Pharmaceutical sector (2017),

«Pedagogical education in university: contextual and biographical approach» (2001). Ed. by А. L. Gavrikova, М. N. Pevznera, Velikij Novgorod : Yaroslav Mudryj Novgorod state university, 300 р.

Bodenheimer, T., Fernandez, A. (2005). High and rising health care costs. Part 1: Seeking an explanation. Annals of Internal Medicine, Vol. 142, Pp. 847–854.

Conrad, P., Leiter, C. V. (2004). Medicalization, Markets and Consumers. Journal of Health and Social Behavior, Vol. 45, Pp.158–176.

Conrad, P. (2007). The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders, Baltimore : Johns Hopkins University Press, 224 p.

Conrad, P., Leiter, V. (2008). From Lydia Pinkham to Queen Levitra: Direct-to-consumer advertising and medicalisation. Sociology of Health & Illness, Vol. 30, Pp. 825–838.

Foucault, M. (1999). The birth of the clinic, Translated by P. Pieniążek, Warszaw : KR Publishing, 265 p.

Goffman, E. (1980). The characteristics of total institutions, A sociological reader on complex organizations, NY : Holt, Rinehart and Winston, P. 319, 559 p.

Kaczmarek, E. (2015). «Ethical challenges in pharmaceutical industry». Annales. Ethics in bussiness life, Vol. 18, No 3, Pp. 99–108.

Kramer P. (1993). Listening to Prozac, New York: Viking, 409 p.

Kutzin, J. (2013). Health financing for universal coverage and health system performance: concepts and implications for policy. Bulletin of the World Health Organization, Vol. 91, Pp. 602–611, doi:http://dx.doi. org/10.2471/BLT.12.113985

Mulley, A., Coulter, A., Wolpert, M., Richards, T. (2017). New approaches to measurement and management for high integrity health systems. British Medical Association, Vol. 356, doi:

Poławski, P., Buczek, J. (2011). «The medicalization of social control. Healthcare and consumption of medicine in Poland. Identification and regulation of social problems», Warszaw: IPSiR UW, 236 p., Pp.82–100.

Rubertone, M. V., Brundage, J. F. (2002). The defense medical surveillance system and the Department of Defense Serum Repository: Glimpses of the future of public health surveillance. II American Journal of Public Health, Vol. 92, No. 12, Pp. 1900–1904.

Schneider M. J., Schneider H. S. (2017). Introduction to public health, Burlington. Jones & Bartlett Learning, MA. 547 p.

Sheikh, S., Furnham, S. (2000). A cross-cultural study of mental health beliefs and attitudes towards seeking professional help. Social Psychiatry and Psychiatric Epidemiology, Vol. 35, Pp. 226–334.

Silver, H. (2004). Evaluation Research in Education, Faculty of Education, University of Plymouth, 273 р.

Wdowiak, L. (2004). «Today and tomorrow of public medicine and public health». Zdrowie Publiczne, Vol. 114 (2), Рp. 125–126.

Wengler, L. E., Lubomira, E., Adamska-Pietrzak, E., and oth. (2014). Philosophical, social and legal aspects of health sciences. Part 2: Legal issues in health sciences, Vol. 2, Gdańsk : Polish Society for Health Programs, 187 p.

WHO Medicines Policy (2017). index.html

Wojtczak, A. (2009). «Public health as a challenge for the healthcare systems in XXI century», Warszawa: Medical publishing PZWL, 226 р.